MedPath

REAL world efficacy and safety analysis of pembrolizumab KEY truda

Not Applicable
Recruiting
Conditions
Patients with non-small cell lung cancer
Registration Number
JPRN-UMIN000045538
Lead Sponsor
Tha Japan Lung Cancer Society
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
1000
Inclusion Criteria

Not provided

Exclusion Criteria

No special rules

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath